Sammie S. Mosier - 01 Dec 2021 Form 3 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP & Chief Nurse Executive
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
01 Dec 2021
Net transactions value
$0
Form type
3
Filing time
09 Dec 2021, 18:35:55 UTC
Next filing
01 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HCA Common Stock 4,974 01 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HCA Restricted Stock Units 01 Dec 2021 Common Stock 273 Direct F1
holding HCA Restricted Stock Units 01 Dec 2021 Common Stock 545 Direct F1, F2
holding HCA Restricted Stock Units 01 Dec 2021 Common Stock 968 Direct F1, F3
holding HCA Restricted Stock Units 01 Dec 2021 Common Stock 550 Direct F1, F4
holding HCA Stock Appreciation Right 01 Dec 2021 Common Stock 1,840 $173.12 Direct F5
holding HCA Stock Appreciation Right 01 Dec 2021 Common Stock 2,680 $241.81 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of HCA Healthcare, Inc. common stock.
F2 The restricted stock units vest in two equal annual installments beginning January 30, 2022.
F3 The restricted stock units vest in three equal annual installments beginning January 29, 2022.
F4 The restricted stock units vest in four equal annual installments beginning February 3, 2022.
F5 The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022.
F6 The stock appreciation rights vest in four equal annual installments beginning on October 25, 2022.